A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma. [electronic resource]
Producer: 20030604Description: 312-21 p. digitalISSN:- 0030-2414
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Carboplatin -- administration & dosage
- Combined Modality Therapy
- Etoposide -- administration & dosage
- Female
- Filgrastim
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Humans
- Hyperthermia, Induced
- Ifosfamide -- administration & dosage
- Lenograstim
- Male
- Middle Aged
- Recombinant Proteins -- therapeutic use
- Sarcoma -- drug therapy
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.